-
Company Insights
Innovation and Patenting activity of Restore PLC Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Restore PLC Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be delivered...
-
Product Insights
NewLikelihood of Approval Analysis for Acute Ischemic Stroke
Overview How likely is it that the drugs in Acute Ischemic Stroke will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Acute Ischemic Stroke Overview An acute ischemic stroke occurs when a...
-
Product Insights
NewLikelihood of Approval Analysis for Shock
Overview How likely is it that the drugs in Shock will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Shock Overview Shock is a medical condition characterized by a significant and life-threatening...
-
Analyst Opinions
Science-Based Fabric Restoration – Foresights
This report investigates a new science-based laundry formulation advancement that restores fabric quality A patent-pending laundry formulation has shed light on opportunities for product development pertaining to garment life extension, multi-benefit laundry solutions, and science-based solutions.
-
Product Insights
NewLikelihood of Approval Analysis for Arteriosclerosis
Overview How likely is it that the drugs in Arteriosclerosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Arteriosclerosis Overview Arteriosclerosis refers to the thickening and hardening of arteries due to...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Rebyota in Crohn’s Disease (Regional Enteritis)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Rebyota in Crohn's Disease (Regional Enteritis) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rebyota in Crohn's Disease (Regional Enteritis) Drug Details: Fecal microbiota,...
-
Product Insights
NewLikelihood of Approval Analysis for Bleeding And Clotting Disorders
Overview How likely is it that the drugs in Bleeding And Clotting Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bleeding And Clotting Disorders Overview Bleeding and clotting disorders are...
-
Product Insights
NewLikelihood of Approval Analysis for Pituitary Gland Disorders
Overview How likely is it that the drugs in Pituitary Gland Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pituitary Gland Disorders Overview Pituitary gland disorders involve dysregulation of the...
-
Product Insights
NewLikelihood of Approval Analysis for Stem Cell Transplantation
Overview How likely is it that the drugs in Stem Cell Transplantation will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Stem Cell Transplantation Overview Stem cell transplantation, also known as hematopoietic...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vesleteplirsen in Duchenne Muscular Dystrophy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Vesleteplirsen in Duchenne Muscular Dystrophy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vesleteplirsen in Duchenne Muscular Dystrophy Drug Details: Vesleteplirsen is under development...